Identifying rare events in rare diseases.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25424848.
- Also identified by DOI 10.1158/1078-0432.CCR-14-2314.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Utilizing genomic signatures from diagnostic tumor samples to forecast clinical behavior and response to therapy has long been a goal, and we are now poised to further refine how we can identify the relatively rare patients with aggressive neuroblastoma masquerading as patients with a more benign form of the disease. Clin Cancer Res; 21(8); 1782-5. ©2014 AACR. See related article by Oberthuer et al., p. 1904.
Medical subject headings
- Biomarkers, Tumor
- Gene Expression Profiling
- Neuroblastoma